{"id":18086,"date":"2020-10-23T10:37:39","date_gmt":"2020-10-23T10:37:39","guid":{"rendered":"https:\/\/celonpharma.com\/?p=18086"},"modified":"2020-10-23T10:38:25","modified_gmt":"2020-10-23T10:38:25","slug":"scientist-biophysicist-in-metabolic-disorders","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/","title":{"rendered":"Scientist \u2013 Biophysicist in Metabolic Disorders"},"content":{"rendered":"<p><strong><u>Preclinical Development Department CELON PHARMA S.A.<\/u><\/strong><\/p>\n<p style=\"text-align: justify;\">In connection with the realization of the research projects under Smart Growth Operational Program 2014-2020, axis 1.1, 1.2 i 4.1, we hereby announce the recruitment for: <strong>SCIENTIST \u2013 Biophysicist<\/strong> in the Metabolic Disorders Research Group in Preclinical Development Department &#8211; Celon Pharma S.A.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><strong>Major Responsibilities:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Performing high-throughput screening tests (HTS) based on biochemical, biophysical and enzymatic approaches,<\/li>\n<li>Planning, performing, and analyzing experiments aiming at development candidates for drugs for metabolic disorders and neurodegenerative diseases,<\/li>\n<li>Implementation of new techniques into projects,<\/li>\n<li>Documenting performed work.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Requirements: <\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>PhD or MSc degree in the Biophysics, Biotechnology, Pharmacy field or in a relevant Life Science with well documented scientific achievements ; PhD degree is welcome.<\/li>\n<li>Proven, at least 4-year experience in independent research work (e.g. doctoral study or work as scientist\/specialist at academia or pharma company),<\/li>\n<li>In-depth knowledge of molecular interactions and biochemical processes,<\/li>\n<li>A solid understanding of the principles behind protein binding analysis, with a focus on methods determining binding affinities, kinetics, and thermodynamics.<\/li>\n<li>Proficiency in biophysical methods: thermophoresis, BLI, SPR. Ability to troubleshoot and critically analyze data,<\/li>\n<li>Proficiency in work with plate readers and hand-on experience with assays based on reporter genes, FRET, AlphaLISA,<\/li>\n<li>Knowledge of basic molecular biology techniques: ELISA, PCR, qPCR, immunoblot, ELISA,<\/li>\n<li>Basic knowledge of cell-line culturing,<\/li>\n<li>Proficiency in big data handling and analyzing, creating databases.<\/li>\n<li>Excellent knowledge of practical statistics for <em>in vitro<\/em> experiments as well as proficiency in dedicated stat. programs,<\/li>\n<li>Effective documentation of the work: writing scientific publications, reports, manuals,<\/li>\n<li>Professional proficiency in English,<\/li>\n<li>Experience with R or Python is advantageous,<\/li>\n<li>Knowledge of drug development and drug discovery is welcome.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><strong>General requirements:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Proven ability to design, execute and interpret critical experiments independently.<\/li>\n<li>The ability to work independently and collaboratively with diverse multidisciplinary teams,<\/li>\n<li>Self-motivation and willingness to learn new techniques in molecular biology,<\/li>\n<li>Excellent written and oral communication skills,<\/li>\n<li>Enthusiasm and scientific curiosity in the field of metabolism and pain management,<\/li>\n<li>Willingness to undertake new challenges and thinking out-of-the-box.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><strong>We offer:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Participation in the R&amp;D projects focused on novel drug candidates,<\/li>\n<li>Opportunity to participate in all preclinical stages of drug development process,<\/li>\n<li>Work in the cutting-edge research center,<\/li>\n<li>Work in a dynamic, young and interdisciplinary project team,<\/li>\n<li>Collaboration with the excellent institutes in Poland and worldwide,<\/li>\n<li>Opportunity for career development,<\/li>\n<li>Full-time employment and job benefits.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">Candidates are asked to send their applications (CV and a motivation letter in English) to: <a href=\"mailto:rekrutacja@celonpharma.com\">rekrutacja@celonpharma.com<\/a> within 30 days from the date of the announcement. We kindly ask to add in the subject of an email: <strong><em>Scientist<\/em><\/strong><strong><em>2<\/em><\/strong><strong><em>.<\/em><\/strong> We emphasize we will contact selected candidates only.<\/p>\n<p style=\"text-align: justify;\">We kindly ask to enclose the agreement:<\/p>\n<p style=\"text-align: justify;\"><em>\u201cI hereby give consent for my personal data included in my application to be processed for the purposes of the recruitment process under\u00a0 the Personal Data Protection Act as of 29 August 1997, consolidated text: Journal of Laws 2016, item 922 as amended.\u201d<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Preclinical Development Department CELON PHARMA S.A. In connection with the realization of the research projects under Smart Growth Operational Program 2014-2020, axis 1.1, 1.2 i 4.1, we hereby announce the recruitment for: SCIENTIST \u2013 Biophysicist in the Metabolic Disorders Research Group in Preclinical Development Department &#8211; Celon Pharma S.A. Major Responsibilities: Performing high-throughput screening tests<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/\" title=\"ReadScientist \u2013 Biophysicist in Metabolic Disorders\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-18086","post","type-post","status-publish","format-standard","hentry","category-departament-of-preclinical-development"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Preclinical Development Department CELON PHARMA S.A. In connection with the realization of the research projects under Smart Growth Operational Program 2014-2020, axis 1.1, 1.2 i 4.1, we hereby announce the recruitment for: SCIENTIST \u2013 Biophysicist in the Metabolic Disorders Research Group in Preclinical Development Department &#8211; Celon Pharma S.A. Major Responsibilities: Performing high-throughput screening testsRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-23T10:37:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-23T10:38:25+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/\"},\"author\":{\"name\":\"Ma\u0142gorzata Siewierska\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"headline\":\"Scientist \u2013 Biophysicist in Metabolic Disorders\",\"datePublished\":\"2020-10-23T10:37:39+00:00\",\"dateModified\":\"2020-10-23T10:38:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/\"},\"wordCount\":485,\"articleSection\":[\"Career - Departament of Preclinical Development\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/\",\"name\":\"Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2020-10-23T10:37:39+00:00\",\"dateModified\":\"2020-10-23T10:38:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/scientist-biophysicist-in-metabolic-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scientist \u2013 Biophysicist in Metabolic Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\",\"name\":\"Ma\u0142gorzata Siewierska\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/","og_locale":"en_US","og_type":"article","og_title":"Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma","og_description":"Preclinical Development Department CELON PHARMA S.A. In connection with the realization of the research projects under Smart Growth Operational Program 2014-2020, axis 1.1, 1.2 i 4.1, we hereby announce the recruitment for: SCIENTIST \u2013 Biophysicist in the Metabolic Disorders Research Group in Preclinical Development Department &#8211; Celon Pharma S.A. Major Responsibilities: Performing high-throughput screening testsRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/","og_site_name":"Celon Pharma","article_published_time":"2020-10-23T10:37:39+00:00","article_modified_time":"2020-10-23T10:38:25+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/"},"author":{"name":"Ma\u0142gorzata Siewierska","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"headline":"Scientist \u2013 Biophysicist in Metabolic Disorders","datePublished":"2020-10-23T10:37:39+00:00","dateModified":"2020-10-23T10:38:25+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/"},"wordCount":485,"articleSection":["Career - Departament of Preclinical Development"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/","url":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/","name":"Scientist \u2013 Biophysicist in Metabolic Disorders - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2020-10-23T10:37:39+00:00","dateModified":"2020-10-23T10:38:25+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/scientist-biophysicist-in-metabolic-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Scientist \u2013 Biophysicist in Metabolic Disorders"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c","name":"Ma\u0142gorzata Siewierska"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/18086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=18086"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/18086\/revisions"}],"predecessor-version":[{"id":18088,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/18086\/revisions\/18088"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=18086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=18086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=18086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}